Biosimilar

（重定向自Biogeneric）

The 2012–2019 patent cliff.[20] Period of market exclusivity up to date of patent expiration for the ten top-selling biologics for 2011. *Enbrel has been granted approval in 2011 for a patent filed in 1995, extending its patent life further 17 years.

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

单词	Biogeneric
释义	Biogeneric 英语百科 Biosimilar （重定向自Biogeneric） A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
随便看	claw thumpers claw tipping mechanism Clawtoe claw toe Claw Toes Clawtoes Clawton claw tool claw tooth claw treatment claw type clamp claw type yaw probe claw washer claw ... way claw weeder claw winch claw wrench claxbies Claxby claxon Claxton Clay. clay accumulation clay acid clay,activated